EMBC logo

Embecta (EMBC)

Profile

Full Name

Embecta Corp.

Ticker Symbol

EMBC

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 22, 2022

Indexes

Not included

Website

http://www.embecta.com

Employees

2100

Key Details

Price

$12.30(+2.41%)

Market cap

$715.05M(Small cap)

Last Dividend

$0.15

TTM Dividend yield

4.88%

Annual revenue

$1.12B(+0.21% YoY)

Annual EPS

$1.34(+9.84% YoY)

PE ratio

12.30

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$12.30
EMBC price is $12.30

30-Day Relative Volume

0.81
EMBC 30-day relative volume is 0.81

Price Performance

Price Most recent change

+2.41%
EMBC price was up +2.41% on Apr 11, 2025

Price YTD change

-40.44%
EMBC price is down -40.44% since January 1st

Price 1-year change

+11.72%
EMBC price is up +11.72% year-on-year

Price 3-year change

-62.06%
EMBC price is down -62.06% over the past 3 years

Price Range

Price All-time high

$49.00
EMBC price is currently -74.90% below its historical high of $49.00

Price 3-year low

$9.93
EMBC price is currently +23.93% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$715.05M
EMBC market capitalization is $715.05 million

Market cap 3-year change

-61.31%
EMBC market capitalization is down -61.31% over the past 3 years

Market cap All-time high

$2.68B
EMBC market capitalization is currently -73.31% below its historical high of $2.68 billion

Market cap sector rank

73.46%
EMBC market capitalization is higher than 73.46% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.82%
EMBC shares outstanding is up +0.82% year-on-year

Shares Outstanding 3-Year Change

+1.99%
EMBC shares outstanding is up +1.99% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
EMBC beta is 0.86

200-day SMA

$15.44
EMBC price is currently -20.32% below its 200-day simple moving average

50-day SMA

$14.03
EMBC price is currently -12.35% below its 50-day simple moving average

RSI

43.51
EMBC 14-day relative strength index is 43.51

Volume

0.81
EMBC 30-day relative volume is 0.81

ATR

$0.79
EMBC average true range is $0.79

10-day Historical Volatility

71.46%
EMBC 10-day historical volatility is 71.46%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.15
EMBC last dividend was $0.15 per share, with an ex-dividend date of February 28, 2025

Next Dividend

-
EMBC next dividend has not yet been announced

Dividend per share

Dividend per share

$0.60
EMBC annual dividend per share is $0.60

Dividend per share Sector Rank

23.26%
EMBC annual dividend per share is higher than 23.26% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
EMBC {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

-
EMBC annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

4.88%
EMBC annual dividend yield is 4.88%

Dividend yield Sector Rank

84.71%
EMBC annual dividend yield is higher than 84.71% of companies in Healthcare sector

Other

Payout ratio

44.06%
EMBC annual payout ratio is 44.06%

Dividends paid

$34.50M
EMBC annual dividends paid is $34.50 million

Free cash flow

$19.90M
EMBC annual free cash flow is $19.90 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.12B
EMBC annual revenue is $1.12 billion

Revenue Analysts estimate

$1.09B
EMBC annual revenue is currently +3.21% higher than the consensus analysts' forecast

Revenue 1-year change

+0.21%
EMBC annual revenue is up +0.21% year-on-year

Revenue Sector rank

80.96%
EMBC annual revenue is higher than 80.96% of companies in Healthcare sector

EPS

EPS

$1.34
EMBC annual earnings per share is $1.34

EPS Analysts estimate

$2.81
EMBC annual earnings per share is currently -52.38% lower than the consensus analysts' forecast

EPS 1-year change

+9.84%
EMBC annual earnings per share is up +9.84% year-on-year

EPS Sector rank

90.59%
EMBC annual earnings per share is higher than 90.59% of companies in Healthcare sector

Profit

Gross profit

$735.20M
EMBC annual gross profit is $735.20 million

Gross margin

65.46%
EMBC annual gross profit margin is 65.46%

Operating profit

$166.80M
EMBC annual operating income is $166.80 million

Operating margin

14.85%
EMBC annual operating profit margin is 14.85%

Net income

$78.30M
EMBC annual net profit is $78.30 million

Net margin

6.97%
EMBC annual net profit margin is 6.97%

Expenses

Total expenses

$956.30M
EMBC annual total expenses is $956.30 million

Operating expenses

$568.40M
EMBC annual total operating expenses is $568.40 million

Cost of goods sold

$387.90M
EMBC annual cost of goods sold is $387.90 million

Selling, general & administrative expenses

$365.10M
EMBC annual SGA is $365.10 million

Depreciation and amortization

$36.20M
EMBC annual depreciation & amortization is $36.20 million

Interest expense

$112.30M
EMBC annual interest expense is $112.30 million

Income tax

-$34.10M
EMBC annual income tax is -$34.10 million

EBIT & EBITDA

EBIT

$156.50M
EMBC annual earnings before interest & taxes is $156.50 million

EBITDA

$192.70M
EMBC annual EBITDA is $192.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.29B
EMBC annual total assets is $1.29 billion

Non current assets

$524.30M
EMBC annual long term assets is $524.30 million

Current assets

$761.00M
EMBC annual total current assets is $761.00 million

Cash and cash equivalents

$267.50M
EMBC annual cash & cash equivalents is $267.50 million

Accounts receivable

$193.00M
EMBC annual accounts receivable is $193.00 million

Inventory

$171.50M
EMBC annual inventory is $171.50 million

Liabilities

Total liabilities

$2.02B
EMBC annual total liabilities is $2.02 billion

Long term liabilities

$1.65B
EMBC annual total long term liabilities is $1.65 billion

Current liabilities

$374.00M
EMBC annual total current liabilities is $374.00 million

Accounts payable

$91.00M
EMBC annual accounts payable is $91.00 million

Debt

Total debt

$1.61B
EMBC annual total debt is $1.61 billion

Total debt 1-year change

-1.84%
EMBC annual total debt is down -1.84% year-on-year

Long term debt

$1.60B
EMBC annual long term debt is $1.60 billion

Short term debt

$12.90M
EMBC annual short term debt is $12.90 million

Equity & Capital

Shareholders equity

-$738.30M
EMBC annual stockholders equity is -$738.30 million

Book value

-$738.30M
EMBC annual book value is -$738.30 million

Retained earnings

-$498.60M
EMBC annual retained earnings is -$498.60 million

Working capital

$387.00M
EMBC annual working capital is $387.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$35.70M
EMBC annual cash flow from operations is $35.70 million

Cash from operations 1-year change

-47.27%
EMBC annual cash flow from operations is down -47.27% year-on-year

Cash from investing

-$15.80M
EMBC annual cash flow from investing activities is -$15.80 million

Cash from investing 1-year change

+40.38%
EMBC annual cash flow from investing activities is up +40.38% year-on-year

Cash from financing

-$73.40M
EMBC annual cash flow from financing activities is -$73.40 million

Cash from financing 1-year change

-50.72%
EMBC annual cash flow from financing activities is down -50.72% year-on-year

CAPEX

CAPEX

$15.80M
EMBC annual capital expenditures is $15.80 million

CAPEX 1-year change

-40.38%
EMBC annual capital expenditures is down -40.38% year-on-year

Free Cash Flow

Free cash flow

$19.90M
EMBC annual free cash flow is $19.90 million

Free cash flow 1-year change

-51.7%
EMBC annual free cash flow is down -51.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

65.46%
EMBC annual gross profit margin is 65.46%

Operating margin

14.85%
EMBC annual operating profit margin is 14.85%

Net margin

6.97%
EMBC annual net profit margin is 6.97%

ROA & ROE

ROA

6.26%
EMBC annual return on assets is 6.26%

ROE

-10.61%
EMBC annual return on equity is -10.61%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

12.30
EMBC price to earnings ratio is 12.30

PE ratio Sector rank

20.59%
EMBC price to earnings ratio is higher than 20.59% of companies in Healthcare sector

PB Ratio

PB ratio

-0.93
EMBC price to book ratio is -0.93

PB ratio Sector rank

8.55%
EMBC price to book ratio is higher than 8.55% of companies in Healthcare sector

PS Ratio

PS ratio

0.65
EMBC price to sales ratio is 0.65

PS ratio Sector rank

20.77%
EMBC price to sales ratio is higher than 20.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.08B
EMBC enterprise value is $2.08 billion

Enterprise value Sector rank

82.49%
EMBC enterprise value is higher than 82.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

11.53
EMBC EV/EBITDA is 11.53

EV/EBITDA Sector rank

84.45%
EMBC EV/EBITDA is higher than 84.45% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.03
EMBC annual current ratio is 2.03

Quick ratio

1.58
EMBC annual quick ratio is 1.58

Leverage

Debt to equity

-2.13
EMBC annual debt to equity ratio is -2.13

Interest coverage ratio

1.39
EMBC annual interest coverage ratio is 1.39

Risk & Stability

Piotroski F-Score

5
EMBC piotroski f-score is 5

Altman Z-Score

1.31
EMBC altman z-score is 1.31

Analyst ratings

Recent major analysts updates

Apr 10, 25 Mizuho
Neutral
Nov 27, 24 BTIG
Buy
Jul 15, 24 Morgan Stanley
Underweight
May 10, 24 Morgan Stanley
Underweight
Nov 22, 23 Morgan Stanley
Underweight
Oct 18, 23 Morgan Stanley
Underweight
Aug 24, 23 Morgan Stanley
Underweight
Jul 18, 23 Morgan Stanley
Underweight
May 15, 23 Morgan Stanley
Underweight
Jan 6, 23 Morgan Stanley
Underweight

Institutional Ownership

Similar stocks

ABCL logo
AbCellera Biologics (ABCL)
CVAC logo
CureVac NV (CVAC)
HCSG logo
Healthcare Services (HCSG)
PAHC logo
Phibro Animal Health (PAHC)
DAWN logo
Day One Biopharmaceuticals (DAWN)
WEAV logo
Weave Communications (WEAV)
AXGN logo
AxoGen (AXGN)
GYRE logo
Gyre Therapeutics (GYRE)
AMN logo
AMN Healthcare Services (AMN)
  • What is the ticker symbol for Embecta?
  • Does Embecta pay dividends?
  • What sector is Embecta in?
  • What industry is Embecta in?
  • What country is Embecta based in?
  • When did Embecta go public?
  • Is Embecta in the S&P 500?
  • Is Embecta in the NASDAQ 100?
  • Is Embecta in the Dow Jones?
  • When was Embecta's last earnings report?
  • When does Embecta report earnings?
  • Should I buy Embecta stock now?

What is the ticker symbol for Embecta?

The ticker symbol for Embecta is NASDAQ:EMBC

Does Embecta pay dividends?

Yes, Embecta pays dividends. The last payment was $0.15, with an ex-dividend date on February 28, 2025

What sector is Embecta in?

Embecta is in the Healthcare sector

What industry is Embecta in?

Embecta is in the Medical Instruments & Supplies industry

What country is Embecta based in?

Embecta is headquartered in United States

When did Embecta go public?

Embecta's initial public offering (IPO) was on March 22, 2022

Is Embecta in the S&P 500?

No, Embecta is not included in the S&P 500 index

Is Embecta in the NASDAQ 100?

No, Embecta is not included in the NASDAQ 100 index

Is Embecta in the Dow Jones?

No, Embecta is not included in the Dow Jones index

When was Embecta's last earnings report?

Embecta's most recent earnings report was on Feb 6, 2025

When does Embecta report earnings?

The next expected earnings date for Embecta is May 9, 2025

Should I buy Embecta stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page